<- Go Home

Harrow, Inc.

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.

Market Cap

EUR 1.6B

Volume

526.8K

Cash and Equivalents

EUR 72.6M

EBITDA

EUR 2.8M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 122.7M

Profit Margin

72.56%

52 Week High

EUR 59.23

52 Week Low

EUR 8.72

Dividend

N/A

Price / Book Value

26.95

Price / Earnings

-46.69

Price / Tangible Book Value

-11.71

Enterprise Value

EUR 1.7B

Enterprise Value / EBITDA

400.77

Operating Income

-EUR 8.6M

Return on Equity

-50.23%

Return on Assets

-1.68

Cash and Short Term Investments

EUR 74.1M

Debt

EUR 196.1M

Equity

EUR 57.6M

Revenue

EUR 169.1M

Unlevered FCF

EUR 62.6M

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches